FDA adds "black box" warning label to fluoroquinolone antibiotics.
作者信息
Tanne Janice Hopkins
出版信息
BMJ. 2008 Jul 15;337(7662):a816. doi: 10.1136/bmj.a816.
Abstract
摘要
相似文献
1
FDA adds "black box" warning label to fluoroquinolone antibiotics.
BMJ. 2008 Jul 15;337(7662):a816. doi: 10.1136/bmj.a816.
2
Fluoroquinolone-induced tendinopathy.
Nurse Pract. 2009 Jan;34(1):17-8. doi: 10.1097/01.NPR.0000343751.83969.1b.
3
Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk?
Pharmacotherapy. 2016 Jun;36(6):679-93. doi: 10.1002/phar.1761. Epub 2016 Jun 11.
4
Fluoroquinolone antibiotics: Risk often exceeds benefit.
Geriatr Nurs. 2020 Mar-Apr;41(2):181-182. doi: 10.1016/j.gerinurse.2020.03.004. Epub 2020 Mar 25.
5
Impact of FDA black box warning on fluoroquinolone and alternative antibiotic use in southeastern US hospitals.
Infect Control Hosp Epidemiol. 2019 Nov;40(11):1297-1300. doi: 10.1017/ice.2019.247. Epub 2019 Sep 2.
6
Clinical inquiries. Is there much risk in using fluoroquinolones in children?
J Fam Pract. 2008 Aug;57(8):539-40.
7
New Federal Drug Administration Fluoroquinolone Warning and a Practical Approach to Managing Patients.
Conn Med. 2016 Nov;80(10):601-605.
8
Tendinopathy resulting from the use of fluoroquinolones: managing risks.
JAAPA. 2010 Dec;23(12):18-21, 54. doi: 10.1097/01720610-201012000-00005.
9
Fluoroquinolones and tendinopathy: a guide for athletes and sports clinicians and a systematic review of the literature.
J Athl Train. 2014 May-Jun;49(3):422-7. doi: 10.4085/1062-6050-49.2.09. Epub 2014 Apr 24.
10
Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning.
Pharmacoepidemiol Drug Saf. 2020 Jun;29(6):701-707. doi: 10.1002/pds.5018. Epub 2020 May 11.
引用本文的文献
1
Direct Effects of Clinically Relevant Antibiotics on Mitochondrial Respiration.
Int J Mol Sci. 2025 Jun 4;26(11):5379. doi: 10.3390/ijms26115379.
2
Fluoroquinolones and the risk of aortic aneurysm or aortic dissection: evidence from a nationwide nested case-control study paralleled with matched experimental models.
Eur Heart J Open. 2025 Mar 15;5(3):oeaf021. doi: 10.1093/ehjopen/oeaf021. eCollection 2025 May.
3
Analyses of Adverse Drug Reactions to Fluoroquinolones in Spontaneous Reports Before and After the Referral and in Clinical Routine Cases.
Drugs R D. 2025 Mar;25(1):35-55. doi: 10.1007/s40268-024-00499-x. Epub 2025 Jan 21.
4
Management of Lower Urinary Tract Symptoms during the Treatment for Non-Muscle Invasive Bladder Cancer.
Curr Urol Rep. 2025 Jan 6;26(1):24. doi: 10.1007/s11934-024-01250-4.
5
Ciprofloxacin-Induced Encephalopathy.
J Med Cases. 2025 Jan;16(1):11-16. doi: 10.14740/jmc4264. Epub 2024 Dec 21.
6
Risk of Tendon Injury in Patients Treated With Fluoroquinolone (FQ) Vs Non-Fluoroquinolone Antibiotics for Urinary Tract Infection (UTI).
J Pharm Technol. 2024 Dec 22:87551225241303848. doi: 10.1177/87551225241303848.
7
Ciprofloxacin's Structure Causing Fluoride-Related Toxicity: A Case Report.
Curr Drug Saf. 2025;20(4):519-525. doi: 10.2174/0115748863321622240819101438.
8
Prescribing Antibiotics for Children with Acute Conditions in Public Primary Care Clinics in Singapore: A Retrospective Cohort Database Study.
Antibiotics (Basel). 2024 Jul 25;13(8):695. doi: 10.3390/antibiotics13080695.
9
Omadacycline is active and against ciprofloxacin-resistant .
Antimicrob Agents Chemother. 2024 Sep 4;68(9):e0059524. doi: 10.1128/aac.00595-24. Epub 2024 Aug 12.
10
Achilles tendon complications of fluoroquinolone treatment: a molecule-stratified systematic review and meta-analysis.
EFORT Open Rev. 2024 Jul 1;9(7):581-588. doi: 10.1530/EOR-23-0181.
Zotero 插件